IMARC Group’s latest report, titled “Bone Graft and Substitutes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global bone graft and substitutes market reached a value of US$ 2.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2027, exhibiting a CAGR of 6.2% during 2022-2027. offers a comprehensive analysis of the industry, which comprises insights on the Bone Graft and Substitutes Market Demand . The report also includes competitor and regional analysis, and contemporary advancements in the market.
Bone graft and substitutes are synthetic, inorganic, or biologically organic combinations that are utilized for replacing missing bones or defects. They are commercially available in pellets, moldable putty, injectables, and solid block forms. Bone graft and substitutes are composed of osteoconductive matric, osteoinductive proteins, demineralized bone matrix, platelet-rick plasma, tricalcium phosphate ceramics, and other polymer-based substitutes. These materials are thermally nonconductive, bioresorbable in nature, cause no antigen-antibody reaction, and do not evoke an adverse inflammatory response. This, in turn, promotes wound healing, supports mitogenesis of identical bone cells, and aids in new bone formation.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/bone-graft-substitutes-market/requestsample
Competitive Landscape with Key Players:
The competitive landscape of the industry has also been examined along with the profiles of the key players being
- Zimmer Biomet Dental
- DePuy Synthes
- Wright Medical Technology
- Medtronic Plc
- Stryker Corporation
- NuVasive Inc
- Arthrex Inc
- Integra LifeSciences
- Baxter International Inc
- Musculoskeletal Transplant Foundation
- Bacterin International Holdings
- SeaSpine
- LifeNet Health
Bone Graft and Substitutes Market Development:
The global bone graft and substitutes market is primarily being driven by the rising prevalence of musculoskeletal disorders, particularly in the geriatric population. This, in turn, has resulted in the advent of new polymer and ceramic products that have biologically superior characteristics. The development of new manufacturing technologies, such as rapid prototyping and three-dimensional (3D) printing, is further aiding in the fabrication of free-form biomaterial scaffolds for tissue regeneration. Moreover, increasing awareness regarding the benefits of bone regeneration through bone grafts, along with rising inclination toward minimally invasive procedures, is fueling the market growth. Other factors, including the widespread product adoption in facial, spinal, and trauma surgeries and their easy availability in diverse shapes and sizes, are creating a positive outlook for the market further.
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/bone-graft-substitutes-market
Key Market Segmentation:
Breakup by Material Type:
- Allografts
- Machined Allografts
- Demineralized Bone Matrix (DBMs)
- Bone Graft Substitutes
- Bone Morphogenic Proteins (BMPs)
- Synthetic Bone Grafts
- Cell-based Matrices
- Others
Breakup by Application:
- Spinal Fusion
- Trauma
- Joint Reconstruction
- Foot and Ankle
- Dental Bone Grafting
- Craniomaxillofacial
- Others
Breakup by End User:
- Hospitals
- Surgical Centres
- Clinics
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800